https://46267109.hs-sites.com/blog/genome-vs.-exome-analysis-for-rare-disease-diagnosis-what-every-provider-should-knowhttps://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%202%20(2).pngBlog 2 (2)Blog 2 (2)https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Blog%203%20(2).pngBlog 3 (2)Blog 3 (2)https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-2https://46267109.hs-sites.com/hubfs/Blog%204%20(2).pngBlog 4 (2)Blog 4 (2)2026-01-30https://46267109.hs-sites.com/bloghttps://46267109.hs-sites.com/hubfs/Blog%202%20(2).pngBlog 2 (2)Blog 2 (2)https://46267109.hs-sites.com/hubfs/Blog%203%20(2).pngBlog 3 (2)Blog 3 (2)https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Blog%207%20(Clinical%20Phenotyping).pngBlog 7 (Clinical Phenotyping)Blog 7 (Clinical Phenotyping)https://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(2).pngRe-analysis Blog (Blog 5) (2)Re-analysis Blog (Blog 5) (2)https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-2https://46267109.hs-sites.com/hubfs/Blog%206%20(Methylation).pngBlog 6 (Methylation)Blog 6 (Methylation)https://46267109.hs-sites.com/hubfs/Blog%207%20(VUS)%20(1).pngBlog 7 (VUS) (1)Blog 7 (VUS) (1)https://46267109.hs-sites.com/hubfs/MyOme%20Logo%C2%AE_RGB%20w-border%20small.pngMyOme Logo®_RGB w-border smallMyOme Logo®_RGB w-border small2025-10-21https://46267109.hs-sites.com/case-studies2025-08-12https://46267109.hs-sites.com/blog/variants-of-uncertain-significance-vus-in-rare-disease-what-every-provider-should-knowhttps://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(2).pngRe-analysis Blog (Blog 5) (2)Re-analysis Blog (Blog 5) (2)https://46267109.hs-sites.com/hubfs/Blog%207%20(VUS)%20(1).pngBlog 7 (VUS) (1)Blog 7 (VUS) (1)https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Blog%207%20(Clinical%20Phenotyping).pngBlog 7 (Clinical Phenotyping)Blog 7 (Clinical Phenotyping)2026-07-13https://46267109.hs-sites.com/blog/a-new-lens-in-rare-disease-diagnosis-integrating-dna-methylation-into-genomic-diagnosticshttps://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%206%20(Methylation).pngBlog 6 (Methylation)Blog 6 (Methylation)https://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(2).pngRe-analysis Blog (Blog 5) (2)Re-analysis Blog (Blog 5) (2)https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-22026-03-18https://46267109.hs-sites.com/blog/how-genetic-testing-for-breast-cancer-can-lead-to-earlier-detectionhttps://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-22025-10-29https://46267109.hs-sites.com/blog/reanalyzing-the-genome-the-diagnostic-power-of-ongoing-discoveryhttps://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-2https://46267109.hs-sites.com/hubfs/Blog%203%20(2).pngBlog 3 (2)Blog 3 (2)https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(2).pngRe-analysis Blog (Blog 5) (2)Re-analysis Blog (Blog 5) (2)https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(1).pngRe-analysis Blog (Blog 5) (1)Re-analysis Blog (Blog 5) (1)2026-03-04https://46267109.hs-sites.com/blog/three-precision-genomic-trends-defining-2025https://46267109.hs-sites.com/hubfs/Blog%202%20(2).pngBlog 2 (2)Blog 2 (2)https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-2https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/Blog%203%20(2).pngBlog 3 (2)Blog 3 (2)2025-12-19https://46267109.hs-sites.com/blog/whole-genome-sequencing-and-clinical-phenotyping-how-they-work-together-to-enable-a-genetic-diagnosishttps://46267109.hs-sites.com/hubfs/Blog%207%20(Clinical%20Phenotyping)%20(1).pngBlog 7 (Clinical Phenotyping) (1)Blog 7 (Clinical Phenotyping) (1)https://46267109.hs-sites.com/hubfs/Blog%206%20(Methylation).pngBlog 6 (Methylation)Blog 6 (Methylation)https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%204%20(3)-1.pngBlog 4 (3)-1Blog 4 (3)-1https://46267109.hs-sites.com/hubfs/Re-analysis%20Blog%20(Blog%205)%20(2).pngRe-analysis Blog (Blog 5) (2)Re-analysis Blog (Blog 5) (2)https://46267109.hs-sites.com/hubfs/Blog%207%20(Clinical%20Phenotyping).pngBlog 7 (Clinical Phenotyping)Blog 7 (Clinical Phenotyping)2026-04-28https://46267109.hs-sites.com/blog/iprs-prostate-cancer-awarenesshttps://46267109.hs-sites.com/hubfs/Blog%202%20(2).pngBlog 2 (2)Blog 2 (2)https://46267109.hs-sites.com/hubfs/1699140849719.jpeg16991408497191699140849719https://46267109.hs-sites.com/hubfs/line-1.pngline-1line-1https://46267109.hs-sites.com/hubfs/Blog%201-2.pngBlog 1-2Blog 1-22025-11-24